0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

". . . And You Can Fool Some of the People All the Time"

W. E. W.
Am J Dis Child. 1962;103(5):632-633. doi:10.1001/archpedi.1962.02080020647002.
Text Size: A A A
Published online

ABSTRACT

Elsewhere in this issue Kempe and collaborators report on numerous negative findings in the evaluation of Reticulose in a number of virus infections of animal and man. The questions raised by these studies are serious ones indeed. Here is an injectable product widely detailed throughout the country, particularly to general practitioners and pediatricians in rural and smaller urban areas, widely advertised in certain journals, but not in the principal pediatric journals, which claims to be the "first antiviral biotic of proven clinical results."

On the face of it, it would be amazing that a substance which has been available since 1938 and which was used in its early days for nonspecific protein therapy should require resurrection in 1957 as an antiviral substance. The advertising to physicians states that "clinical improvement objectively and subjectively may be anticipated within 24 to 36 hours." The list of diseases "successfully treated" covers the entire

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();